TAGCyx has executed a joint research and development agreement with Teika Pharmaceutical

TAGCyx Biotechnologies and Teika Pharmaceutical announce execution of a joint research and development agreement to develop an ophthalmic formulation of TAGX-0003 for the treatment of dry eye.

Please refer to the following for details. 231211_Press Release_EN